Private Trust Company’s Ascendis Pharma A/S ASND Stock Holding History

Private Trust Company’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11	Closed	-$2.19K	–	2550
2025 Q3	$2.19K	Buy	+11	New	+$2.05K	﹤0.01%	2334
2025 Q2	–	Sell	-26	Closed	-$4.05K	–	2471
2025 Q1	$4.05K	Buy	+26	New	+$3.71K	﹤0.01%	2101
2024 Q3	–	Sell	-39	Closed	-$5.32K	–	2288
2024 Q2	$5.32K	Hold	39	–	–	﹤0.01%	1902
2024 Q1	$5.9K	Sell	39 -5	-11%	-$714	﹤0.01%	1854
2023 Q4	$5.54K	Buy	44 +11	+33%	+$1.1K	﹤0.01%	1882
2023 Q3	$3.09K	Sell	33 -12	-27%	-$1.12K	﹤0.01%	2031
2023 Q2	$4.02K	Buy	+45	New	+$3.92K	﹤0.01%	1943

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Private Trust Company's ASND Position: Q4 2025 in Review

Private Trust Company sold out of Ascendis Pharma A/S (ASND) in Q4 2025, closing a stake of 11 shares — an estimated $2.19K sold.

Private Trust Company first reported a position in ASND in Q2 2023 and held it in 7 quarters. The position peaked at $5.9K in Q1 2024. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

Private Trust Company reported no remaining Ascendis Pharma A/S position as of Q4 2025 after selling out during the quarter.
Private Trust Company sold 11 Ascendis Pharma A/S shares in Q4 2025, an estimated $2.19K.
Private Trust Company first reported a position in Ascendis Pharma A/S in Q2 2023 and held it in 7 quarters.
Private Trust Company's Ascendis Pharma A/S position peaked at $5.9K in Q1 2024.
302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.